(Q45934897)

18 December 2017

title

Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium. (English)

1 reference

18 December 2017

1 reference

6

1 reference

18 December 2017

author name string

M Anthony

1

1 reference

18 December 2017

K Romero

2

1 reference

18 December 2017

D C Malone

3

1 reference

18 December 2017

L E Hines

4

1 reference

18 December 2017

L Higgins

5

1 reference

18 December 2017

language of work or name

English

0 references

publication date

8 July 2009

1 reference

18 December 2017

number of pages

5

1 reference

Clinical Pharmacology & Therapeutics

inferred from page(s)

published in

1 reference

18 December 2017

volume

86

1 reference

18 December 2017

issue

4

1 reference

18 December 2017

page(s)

425-429

1 reference

18 December 2017

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

Interaction of warfarin with drugs, natural substances, and foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

Systematic overview of warfarin and its drug and food interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

Utilization review of concomitant use of potentially interacting drugs in Thai patients using warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

The potential for interaction between warfarin and coprescribed medication: a retrospective study in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

Concordance of severity ratings provided in four drug interaction compendia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

The impact of computerized physician order entry on medication error prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

The safety of warfarin therapy in the nursing home setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

Physicians' decisions to override computerized drug alerts in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

Computer-based drug-utilization review--risk, benefit, or boondoggle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

Assessment of potential drug-drug interactions with a prescription claims database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Anticoagulation Guidelines Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

7 January 2021

Systems analysis of adverse drug events. ADE Prevention Study Group

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

7 January 2021

Effects of fluvastatin and cigarette smoking on CYP2C9 activity measured using the probe S-warfarin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

7 January 2021

Lovastatin. Warfarin interaction

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

7 January 2021

Hypoprothrombinemia due to propylthiouracil therapy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

7 January 2021

Prolonged Intraoperative Bleeding Caused by Propylthiouracil-induced Hypoprothrombinemia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

7 January 2021

HYPOPROTHROMBINEMIA AS A COMPLICATION OF PROPYLTHIOURACIL

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.95

7 January 2021

Identifiers

DOI

10.1038/CLPT.2009.95

1 reference

18 December 2017

1 reference

18 December 2017